Technical Analysis for BDSX - Biodesix, Inc.

Grade Last Price % Change Price Change
C 1.58 0.96% 0.02
BDSX closed up 0.96 percent on Friday, May 17, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
NR7 Range Contraction 0.96%
NR7-2 Range Contraction 0.96%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests provide physicians with timely results to facilitate treatment decisions. It also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated 2005 and is headquartered in Boulder, Colorado.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biopharmaceutical Clinical Research Lung Cancer Companion Diagnostic Diagnostic Solutions

Is BDSX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.21
52 Week Low 1.03
Average Volume 149,181
200-Day Moving Average 1.56
50-Day Moving Average 1.39
20-Day Moving Average 1.41
10-Day Moving Average 1.54
Average True Range 0.08
RSI (14) 66.10
ADX 22.85
+DI 26.10
-DI 15.53
Chandelier Exit (Long, 3 ATRs) 1.38
Chandelier Exit (Short, 3 ATRs) 1.45
Upper Bollinger Bands 1.69
Lower Bollinger Band 1.13
Percent B (%b) 0.8
BandWidth 39.65
MACD Line 0.06
MACD Signal Line 0.04
MACD Histogram 0.0214
Fundamentals Value
Market Cap 142.5 Million
Num Shares 90.5 Million
EPS -0.88
Price-to-Earnings (P/E) Ratio -1.79
Price-to-Sales 3.19
Price-to-Book 6.55
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.61
Resistance 3 (R3) 1.60 1.59 1.60
Resistance 2 (R2) 1.59 1.58 1.59 1.60
Resistance 1 (R1) 1.58 1.58 1.59 1.59 1.60
Pivot Point 1.57 1.57 1.57 1.57 1.57
Support 1 (S1) 1.56 1.56 1.57 1.57 1.55
Support 2 (S2) 1.55 1.56 1.55 1.55
Support 3 (S3) 1.54 1.55 1.55
Support 4 (S4) 1.55